The antiviral medicine has been given full approval in the US after a trial showed it cut recovery time by five days.
We are talking about remdesivir, an antiviral drug administered intravenously. Gilead Sciences said Thursday that its drug is approved for people 12 and older who require hospitalization due to coronavirus infection.
The company has given the drug the commercial name Veklury.
A large US study showed that the drug shortened recovery time by five days, from an average of 15 to 10.
Since spring, the drug has been approved for use in especially severe cases. It suppresses the action of the substance that the virus uses to make copies.